Could an Eye Exam be used to Determine Effectiveness of Multiple Sclerosis Treatment?11:36 AM
For over 2 million people worldwide diagnosed with Multiple Sclerosis, finding a treatment that controls the disease can be both costly and time-consuming where time is of the essence. With MS, trial and error with a drug could mean the difference in permanent debilitation. Luckily, more and more promising drugs are hitting the market. Newly launched Tecfidera is one of the most promising oral medications (and for those with MS, an oral treatment is a brave new world because traditional medications have required daily injections!), but comes with a hefty price tag around $54,000 for a year of treatment. Like all medications, you won't know if it works for you with the same effectivity seen in trial data. New research from Johns Hopkins suggests that your eye doctor may be able to work in conjunction with your primary care provider to track if your MS medication is working effectively for you!
|OCT imaging showing the thickness of individual retinal layers|